Our Environmental, Social and Governance (ESG) mission and responsible business strategy

Oxford Biomedica’s ESG mission is to deliver life changing cell and gene therapies to patients in an ethical and socially responsible way

We are committed to our role as a responsible business and we have a strategy in place to drive us towards achieving our ESG mission.

Responsible Business Strategy

ESG Diagram

Our responsible business strategy is focused on five pillars: People; Community; Environment; Innovation and Supply Chain. For more details see the ESG section of the Annual report and accounts (starting page 42).

Oxford Biomedica’s ESG Committee is responsible for the governance and oversight of our ESG commitments.

The ESG Committee is responsible for tracking progress against the objectives and providing regular progress reports to the Corporate Executive Team every quarter. Progress updates are also shared in all-company meetings, and to the Board.


Oxford Biomedica’s three values, “Integrity, Innovation, and Inspiration”, govern the way that Oxford Biomedica does business, how Oxford Biomedica works together, and the interactions Oxford Biomedica has with all its stakeholders.

Oxford Biomedica’s values and the associated behaviours are embedded throughout its people processes, including recruitment practices, seeking evidence that job candidates share the Group’s values upon appointment. The values are an important feature in the Group’s reward principles. Its performance management processes ensure that employee behaviours which align with its values are appropriately recognised and rewarded.

The Group’s values

Have integrity

We always do the right thing. Whatever the situation and consequences, we do what’s right for employees, patients and partners. We make objective decisions and can be trusted to deliver on our commitments.

Be inspiring

We succeed together through our passion, commitment and teamwork. Through our actions and behaviours, we create an environment which positively challenges, engages and excites us.

Deliver innovation

We deliver ground-breaking scientific excellence by nurturing exceptional talent. Together, we continually improve by generating new ideas and creative ways of working to bring about better solutions for patients.

Our commitment to responsible business practices has been recognised with Prime status (as of 25 June 2021).

ISS ESG is the responsible investment arm of ISS and one of the world’s leading rating agencies for sustainable investments. Prime status is awarded to companies with an ESG performance above the sector-specific Prime threshold, which means that they fulfil ambitious absolute performance requirements. For more info: https://www.issgovernance.com/esg/ratings/

The Group’s commitment to responsible business practices were recognised with inclusion in the FTSE4Good index in June 2022. Created by the global index provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE4Good indices are used by a wide variety of market participants to create and assess responsible investment funds and other products.